CCL5 secreted from bone marrow stromal cells stimulates the migration and invasion of Huh7 hepatocellular carcinoma cells via the PI3K-Akt pathway

Bai,Huili; Weng,Yaguang; Bai,Shunjie; Jiang,Yingjiu; Li,Baolin; He,Fang; Zhang,Ruyi; Yan,Shujuan; Deng,Fang; Wang,Jing; Shi,Qiong

doi:10.3892/ijo.2014.2421

CCL5 secreted from bone marrow stromal cells stimulates the migration and invasion of Huh7 hepatocellular carcinoma cells via the PI3K-Akt pathway

Authors:
- Huili Bai
- Yaguang Weng
- Shunjie Bai
- Yingjiu Jiang
- Baolin Li
- Fang He
- Ruyi Zhang
- Shujuan Yan
- Fang Deng
- Jing Wang
- Qiong Shi
View Affiliations

Affiliations: Key Laboratory of Diagnostic Medicine Designated by the Chinese Ministry of Education, Chongqing Medical University, Chongqing 400016, P.R. China, The First Affiliated Hospital, Chongqing Medical University, Chongqing 400016, P.R. China
Published online on: May 6, 2014 https://doi.org/10.3892/ijo.2014.2421
Pages: 333-343

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

Bone metastases from hepatocellular carcinoma (HCC) seem to be increasing. Previous studies showed that soluble factors secreted by host cells and direct cell-to-cell interactions contributed to the preferential metastasis and growth of cancer cells in bone, while the underlying mechanism(s) of the metastasis of HCC in the bone are poorly understood. Here, we determined the effect of HS-5 cells on Huh7 cell proliferation, and investigated the role of CCL5 from HS-5 cells on the development of Huh7 cells. In addition, the underlying mechanisms on the influence in Huh7 cells were investigated. Our results showed that HS-5 cells could promote the proliferation, migration and invasion of Huh7 cells, and inhibited apoptosis. CCL5 downregulation was able to inhibit the effects of HS-5 cells on Huh7 cell migration and invasion via the PI3K-Akt signaling pathway and reduce MMP-2 expression. Therefore, these findings suggest that CCL5 secreted from MSCs can promote the migration and invasion of Huh7 cells and could be an important factor in HCC related to occurrence of bone metastases.

View Figures

View References

1.	Yang JD and Roberts LR: Hepatocellular carcinoma: A global view. Nat Rev Gastroenterol Hepatol. 7:448–458. 2010. View Article : Google Scholar : PubMed/NCBI
2.	Ma W, Wong CC, Tung EK, Wong CM and Ng IO: RhoE is frequently down-regulated in hepatocellular carcinoma (HCC) and suppresses HCC invasion through antagonizing the Rho/Rho-kinase/myosin phosphatase target pathway. Hepatology. 57:152–161. 2013. View Article : Google Scholar : PubMed/NCBI
3.	Ho CL, Chen S, Yeung DW and Cheng TK: Dual-tracer PET/CT imaging in evaluation of metastatic hepatocellular carcinoma. J Nucl Med. 48:902–909. 2007. View Article : Google Scholar : PubMed/NCBI
4.	Natsuizaka M, Omura T, Akaike T, et al: Clinical features of hepatocellular carcinoma with extrahepatic metastases. J Gastroenterol Hepatol. 20:1781–1787. 2005. View Article : Google Scholar : PubMed/NCBI
5.	Xiang ZL, Zeng ZC, Tang ZY, et al: Chemokine receptor CXCR4 expression in hepatocellular carcinoma patients increases the risk of bone metastases and poor survival. BMC Cancer. 9:1762009. View Article : Google Scholar : PubMed/NCBI
6.	Paget S: The distribution of secondary growths in cancer of the breast. 1889. Cancer Metastasis Rev. 8:98–101. 1989.PubMed/NCBI
7.	Chung LW, Baseman A, Assikis V and Zhau HE: Molecular insights into prostate cancer progression: the missing link of tumor microenvironment. J Urol. 173:10–20. 2005. View Article : Google Scholar : PubMed/NCBI
8.	Chackal-Roy M, Niemeyer C, Moore M and Zetter BR: Stimulation of human prostatic carcinoma cell growth by factors present in human bone marrow. J Clin Invest. 84:43–50. 1989. View Article : Google Scholar : PubMed/NCBI
9.	Klopp AH, Gupta A, Spaeth E, Andreeff M and Marini F III: Concise review: Dissecting a discrepancy in the literature: do mesenchymal stem cells support or suppress tumor growth? Stem Cells. 29:11–19. 2011. View Article : Google Scholar : PubMed/NCBI
10.	Maestroni GJ, Hertens E and Galli P: Factor(s) from nonmacrophage bone marrow stromal cells inhibit Lewis lung carcinoma and B16 melanoma growth in mice. Cell Mol Life Sci. 55:663–667. 1999. View Article : Google Scholar : PubMed/NCBI
11.	Kucerova L, Matuskova M, Hlubinova K, Altanerova V and Altaner C: Tumor cell behaviour modulation by mesenchymal stromal cells. Mol Cancer. 9:1292010. View Article : Google Scholar : PubMed/NCBI
12.	Karnoub AE, Dash AB, Vo AP, et al: Mesenchymal stem cells within tumour stroma promote breast cancer metastasis. Nature. 449:557–563. 2007. View Article : Google Scholar : PubMed/NCBI
13.	Lin JT, Wang JY, Chen MK, et al: Colon cancer mesenchymal stem cells modulate the tumorigenicity of colon cancer through interleukin 6. Exp Cell Res. 319:2216–2229. 2013. View Article : Google Scholar : PubMed/NCBI
14.	Khakoo AY, Pati S, Anderson SA, et al: Human mesenchymal stem cells exert potent antitumorigenic effects in a model of Kaposi’s sarcoma. J Exp Med. 203:1235–1247. 2006.PubMed/NCBI
15.	Zhang C, Soori M, Miles FL, et al: Paracrine factors produced by bone marrow stromal cells induce apoptosis and neuroendocrine differentiation in prostate cancer cells. Prostate. 71:157–167. 2011. View Article : Google Scholar : PubMed/NCBI
16.	Hernanda PY, Pedroza-Gonzalez A, van der Laan LJ, et al: Tumor promotion through the mesenchymal stem cell compartment in human hepatocellular carcinoma. Carcinogenesis. 34:2330–2340. 2013. View Article : Google Scholar : PubMed/NCBI
17.	Mizuguchi T, Hui T, Palm K, et al: Enhanced proliferation and differentiation of rat hepatocytes cultured with bone marrow stromal cells. J Cell Physiol. 189:106–119. 2001. View Article : Google Scholar : PubMed/NCBI
18.	Jing Y, Han Z, Liu Y, et al: Mesenchymal stem cells in inflammation microenvironment accelerates hepatocellular carcinoma metastasis by inducing epithelial-mesenchymal transition. PLoS One. 7:e432722012. View Article : Google Scholar
19.	Li GC, Ye QH, Dong QZ, Ren N, Jia HL and Qin LX: Mesenchymal stem cells seldomly fuse with hepatocellular carcinoma cells and are mainly distributed in the tumor stroma in mouse models. Oncol Rep. 29:713–719. 2013.PubMed/NCBI
20.	Li GC, Ye QH, Xue YH, et al: Human mesenchymal stem cells inhibit metastasis of a hepatocellular carcinoma model using the MHCC97-H cell line. Cancer Sci. 101:2546–2553. 2010. View Article : Google Scholar : PubMed/NCBI
21.	Niess H, Bao Q, Conrad C, et al: Selective targeting of genetically engineered mesenchymal stem cells to tumor stroma microenvironments using tissue-specific suicide gene expression suppresses growth of hepatocellular carcinoma. Ann Surg. 254:767–775. 2011. View Article : Google Scholar
22.	Qiao L, Xu Z, Zhao T, et al: Suppression of tumorigenesis by human mesenchymal stem cells in a hepatoma model. Cell Res. 18:500–507. 2008. View Article : Google Scholar : PubMed/NCBI
23.	Ho IA, Toh HC, Ng WH, et al: Human bone marrow-derived mesenchymal stem cells suppress human glioma growth through inhibition of angiogenesis. Stem Cells. 31:146–155. 2013. View Article : Google Scholar : PubMed/NCBI
24.	Sahin H, Trautwein C and Wasmuth HE: Functional role of chemokines in liver disease models. Nat Rev Gastroenterol Hepatol. 7:682–690. 2010. View Article : Google Scholar : PubMed/NCBI
25.	Makinoshima H and Dezawa M: Pancreatic cancer cells activate CCL5 expression in mesenchymal stromal cells through the insulin-like growth factor-I pathway. FEBS Lett. 583:3697–3703. 2009. View Article : Google Scholar : PubMed/NCBI
26.	Luther SA and Cyster JG: Chemokines as regulators of T cell differentiation. Nat Immunol. 2:102–107. 2001. View Article : Google Scholar : PubMed/NCBI
27.	Charni F, Friand V, Haddad O, et al: Syndecan-1 and syndecan-4 are involved in RANTES/CCL5-induced migration and invasion of human hepatoma cells. Biochim Biophys Acta. 1790:1314–1326. 2009. View Article : Google Scholar : PubMed/NCBI
28.	Sutton A, Friand V, Papy-Garcia D, et al: Glycosaminoglycans and their synthetic mimetics inhibit RANTES-induced migration and invasion of human hepatoma cells. Mol Cancer Ther. 6:2948–2958. 2007. View Article : Google Scholar : PubMed/NCBI
29.	Liou JM, Lin JT, Huang SP, et al: RANTES-403 polymorphism is associated with reduced risk of gastric cancer in women. J Gastroenterol. 43:115–123. 2008. View Article : Google Scholar : PubMed/NCBI
30.	Kondo T, Ito F, Nakazawa H, Horita S, Osaka Y and Toma H: High expression of chemokine gene as a favorable prognostic factor in renal cell carcinoma. J Urol. 171:2171–2175. 2004. View Article : Google Scholar : PubMed/NCBI
31.	Honczarenko M, Le Y, Swierkowski M, Ghiran I, Glodek AM and Silberstein LE: Human bone marrow stromal cells express a distinct set of biologically functional chemokine receptors. Stem Cells. 24:1030–1041. 2006. View Article : Google Scholar : PubMed/NCBI
32.	Tyner JW, Uchida O, Kajiwara N, et al: CCL5-CCR5 interaction provides antiapoptotic signals for macrophage survival during viral infection. Nat Med. 11:1180–1187. 2005. View Article : Google Scholar : PubMed/NCBI
33.	Bao M, Chen Z, Xu Y, et al: Sphingosine kinase 1 promotes tumour cell migration and invasion via the S1P/EDG1 axis in hepatocellular carcinoma. Liver Int. 32:331–338. 2012. View Article : Google Scholar : PubMed/NCBI
34.	Palagyi A, Neveling K, Plinninger U, et al: Genetic inactivation of the Fanconi anemia gene FANCC identified in the hepatocellular carcinoma cell line HuH-7 confers sensitivity towards DNA-interstrand crosslinking agents. Mol Cancer. 9:1272010. View Article : Google Scholar
35.	Shi F, Shi M, Zeng Z, et al: PD-1 and PD-L1 upregulation promotes CD8(+) T-cell apoptosis and postoperative recurrence in hepatocellular carcinoma patients. Int J Cancer. 128:887–896. 2011.
36.	Chen J, Liu WB, Jia WD, et al: Overexpression of mortalin in hepatocellular carcinoma and its relationship with angiogenesis and epithelial to mesenchymal transition. Int J Oncol. 44:247–255. 2014.PubMed/NCBI
37.	Montella L, Addeo R, Palmieri G, et al: Zoledronic acid in the treatment of bone metastases by hepatocellular carcinoma: a case series. Cancer Chemother Pharmacol. 65:1137–1143. 2010. View Article : Google Scholar : PubMed/NCBI
38.	Crawford BA, Kam C, Pavlovic J, et al: Zoledronic acid prevents bone loss after liver transplantation: a randomized, double-blind, placebo-controlled trial. Ann Intern Med. 144:239–248. 2006. View Article : Google Scholar : PubMed/NCBI
39.	Lu YR, Yuan Y, Wang XJ, et al: The growth inhibitory effect of mesenchymal stem cells on tumor cells in vitro and in vivo. Cancer Biol Ther. 7:245–251. 2008. View Article : Google Scholar : PubMed/NCBI
40.	Wang SW, Wu HH, Liu SC, et al: CCL5 and CCR5 interaction promotes cell motility in human osteosarcoma. PLoS One. 7:e351012012. View Article : Google Scholar : PubMed/NCBI
41.	Cambien B, Richard-Fiardo P, Karimdjee BF, et al: CCL5 neutralization restricts cancer growth and potentiates the targeting of PDGFRβ in colorectal carcinoma. PLoS One. 6:e288422011.PubMed/NCBI
42.	Vaday GG, Peehl DM, Kadam PA and Lawrence DM: Expression of CCL5 (RANTES) and CCR5 in prostate cancer. Prostate. 66:124–134. 2006. View Article : Google Scholar : PubMed/NCBI
43.	Gallo M, De Luca A, Lamura L and Normanno N: Zoledronic acid blocks the interaction between mesenchymal stem cells and breast cancer cells: implications for adjuvant therapy of breast cancer. Ann Oncol. 23:597–604. 2012. View Article : Google Scholar
44.	Long H, Xie R, Xiang T, et al: Autocrine CCL5 signaling promotes invasion and migration of CD133⁺ ovarian cancer stem-like cells via NF-κB-mediated MMP-9 upregulation. Stem Cells. 30:2309–2319. 2012.
45.	Barashi N, Weiss ID, Wald O, et al: Inflammation-induced hepatocellular carcinoma is dependent on CCR5 in mice. Hepatology. 58:1021–1030. 2013. View Article : Google Scholar
46.	Orimo A, Gupta PB, Sgroi DC, et al: Stromal fibroblasts present in invasive human breast carcinomas promote tumor growth and angiogenesis through elevated SDF-1/CXCL12 secretion. Cell. 121:335–348. 2005. View Article : Google Scholar : PubMed/NCBI
47.	Mo W, Chen J, Patel A, et al: CXCR4/CXCL12 mediate autocrine cell-cycle progression in NF1-associated malignant peripheral nerve sheath tumors. Cell. 152:1077–1090. 2013. View Article : Google Scholar : PubMed/NCBI
48.	Liu H, Pan Z, Li A, et al: Roles of chemokine receptor 4 (CXCR4) and chemokine ligand 12 (CXCL12) in metastasis of hepatocellular carcinoma cells. Cell Mol Immunol. 5:373–378. 2008. View Article : Google Scholar : PubMed/NCBI
49.	Li X, Yang Z, Song W, et al: Overexpression of Bmi-1 contributes to the invasion and metastasis of hepatocellular carcinoma by increasing the expression of matrix metalloproteinase (MMP)-2, MMP-9 and vascular endothelial growth factor via the PTEM/PI3K/Akt pathway. Int J Oncol. 43:793–802. 2013.PubMed/NCBI
50.	Suthiphongchai T, Promyart P, Virochrut S, Tohtong R and Wilairat P: Involvement of ERK1/2 in invasiveness and metastatic development of rat prostatic adenocarcinoma. Oncol Res. 13:253–259. 2003.PubMed/NCBI
51.	Diaz-Gil JJ, Garcia-Monzon C, Rua C, et al: The anti-fibrotic effect of liver growth factor is associated with decreased intrahepatic levels of matrix metalloproteinases 2 and 9 and transforming growth factor beta 1 in bile ductligated rats. Histol Histopathol. 23:583–591. 2008.PubMed/NCBI
52.	Roomi MW, Kalinovsky T, Rath M and Niedzwiecki A: In vitro modulation of MMP-2 and MMP-9 in pediatric human sarcoma cell lines by cytokines, inducers and inhibitors. Int J Oncol. 44:27–34. 2014.
53.	Xiang ZL, Zeng ZC, Fan J, et al: Gene expression profiling of fixed tissues identified hypoxia-inducible factor-1α, VEGF, and matrix metalloproteinase-2 as biomarkers of lymph node metastasis in hepatocellular carcinoma. Clin Cancer Res. 17:5463–5472. 2011.PubMed/NCBI
54.	Wang YH, Dong YY, Wang WM, et al: Vascular endothelial cells facilitated HCC invasion and metastasis through the Akt and NF-κB pathways induced by paracrine cytokines. J Exp Clin Cancer Res. 32:512013.PubMed/NCBI
55.	Gao J, Ding F, Liu Q and Yao Y: Knockdown of MACC1 expression suppressed hepatocellular carcinoma cell migration and invasion and inhibited expression of MMP2 and MMP9. Mol Cell Biochem. 376:21–32. 2013. View Article : Google Scholar : PubMed/NCBI